Charles Horn
Corporate Officer/Principal at SOLENO THERAPEUTICS, INC.
Network origin in Charles Horn first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charles Horn via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Sales & Marketing | |
| DOW CHEMICAL COMPANY (THE) | Chemicals: Specialty | Corporate Officer/Principal | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Director/Board Member | |
| TITAN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| INVUITY INC | Medical Distributors | Director of Finance/CFO Human Resources Officer | |
| HSBC Global Markets Select Funds Plc | Investment Trusts/Mutual Funds | Director/Board Member | |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Abingworth Bioventures VI LP
 Abingworth Bioventures VI LP Investment ManagersFinance Abingworth Bioventures VI LP invests in private and public companies located the US and Europe. The fund targets companies operating in the fields of medical devices, instrumentation, bio therapeutics, small molecules, nucleic acid therapeutics, vaccines, specialty pharma, technologies, diagnostics and software. The fund provides financing for seed, early and late stage capital requirements with an investment size of $15 - $30 million. It seeks Majority or minority investments in the companies. | Investment Managers | Director/Board Member | |
| Michigan State University | College/University | Graduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Analyst | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Iowa State University | College/University | Doctorate Degree | |
Triton Container International Ltd.
 Triton Container International Ltd. Other TransportationTransportation Triton Container International Ltd. operates marine cargo container fleet. It offers dry van, refrigerated, flat rack, and open top equipment. The company was founded by Edward Schneider in 1980 and is headquartered in Hamilton, Bermuda. | Other Transportation | Human Resources Officer | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Colorado College provide a broad liberal arts education to students. The college was founded in May 6, 1874 and it is headquartered in Colorado Springs, CO | College/University | Undergraduate Degree | |
| Concordia University-Irvine | College/University | Director/Board Member | |
U4EA Wireless, Inc.
 U4EA Wireless, Inc. Computer PeripheralsElectronic Technology U4EA Wireless, Inc. designs, develops, manufactures, markets and sells Wi-Fi networking equipment. The company was founded in 2000 and is headquartered in Fremont, CA. | Computer Peripherals | Director of Finance/CFO | |
| Scripps College | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree | |
| University of Indianapolis | College/University | Masters Business Admin | |
| University of San Francisco | College/University | Graduate Degree | |
| University of Toledo Medical Center | College/University | Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
HSBC Bank Plc (Broker)
 HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| King's College London | College/University | Undergraduate Degree | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SMS Medical College & Hospital | College/University | Undergraduate Degree | |
| PHARMAESSENTIA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Genzyme Danmark | Corporate Officer/Principal | ||
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
FLG Partners LLC
 FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services FLG Partners LLC is a CFO solutions, CEO, and board advisory services provider based in Silicon Valley. The private company is based in Palo Alto, CA, and has subsidiaries in the United States. The company offers financial and operational leadership to a wide range of companies, from newly funded startups to Fortune 100 companies, across various sectors, including technology, life sciences, and consumer products. The firm's partners engage clients in interim or long-term assignments in leadership roles that typically are consulting engagements. FLG Partners has helped raise over $6 billion in growth financing, IPO, and M&A transactions for the firm's clients since January 2021. The company was founded by Douglas J. Lehrmann, Jeffrey S. Kuhn, Kyle W. Smith. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member | |
| The Big C Society | Director/Board Member | ||
Entact Bio, Inc.
 Entact Bio, Inc. BiotechnologyHealth Technology Entact Bio, Inc. is a company that focuses on creating new medicines by enhancing protein function. The company is based in Watertown, MA. The company is a team of scientists, entrepreneurs, drug creators, and problem solvers who work together to bring new medicines to patients who currently have few options. The CEO of the company is Victoria M. Richon. The founder of the company grew up in chaos and instability in an undisclosed capital city and has always been passionate and motivated to help enhance and provide medical solutions. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 31 |
| United Kingdom | 10 |
| Denmark | 5 |
| Sweden | 3 |
| Ireland | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 14 |
| Finance | 6 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 69 |
| Independent Dir/Board Member | 30 |
| Corporate Officer/Principal | 25 |
| Chairman | 13 |
| Chief Executive Officer | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Ernest Mario | 44 |
| Gwen Melincoff | 20 |
| Andrew Sinclair | 14 |
| Matthew Pauls | 14 |
| Birgitte Volck | 13 |
| James Mackaness | 12 |
| Bill Harris | 8 |
| Neil M. Cowen | 8 |
| Meredith S. Manning | 6 |
| Kristen Yen | 5 |
| Lauren Budesheim | 5 |
| Anish Bhatnagar | 4 |
| Patricia Hirano | 4 |
| Michael Woloschak | 4 |
- Stock Market
- Insiders
- Charles Horn
- Company connections
